BORTIAD(Bortezomib Injection)
Therapeutic class: proteasome inhibitor
Indication: Multiple Myeloma, Mantle Cell Lymphoma
- 2mg Lyophilized for SC/IV Use
- 20°C - 25°C (68°F - 77°F) , Shelf Life: 2 Years
- As directed by the physician
